Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 463
Selected: 0
NCT IDTitle
NCT03351062Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT04213937Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer
NCT05511051A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy
NCT04769388Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib
NCT06287320The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
NCT06314542Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
NCT04389073Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
NCT07083375A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
NCT02933294Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer
NCT03874871Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT07187154The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NCT06839560Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain Metastasis
NCT03844360Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
NCT01829841A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer
NCT06498752MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
NCT06761417A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults
NCT06793813Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06115837Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT07026669A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT05541445Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT06146946Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT06501976An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy
NCT06082180A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT06791161A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT06202001Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients
NCT03751592Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
NCT07048964A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations
NCT06389422Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
NCT06163729Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma
NCT06405295Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation
NCT03381430Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
NCT05392699ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
NCT06405139Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer
NCT02487316A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
NCT0608476768Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT05865132Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction
NCT06430658Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer
NCT04443478Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT06585878A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
NCT02992353Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer
NCT03511170XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
NCT02560441Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
NCT03392220A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer
NCT05607225Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT06820320Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy
NCT07166003Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT05904015The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC